Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Net Income (2016 - 2024)

Historic Net Income for Mimedx (MDXG) over the last 15 years, with Q3 2024 value amounting to $217000.0.

  • Mimedx's Net Income rose 17045.45% to $217000.0 in Q3 2024 from the same period last year, while for Jun 2025 it was $217000.0, marking a year-over-year decrease of 8959.23%. This contributed to the annual value of $421000.0 for FY2024, which is 10457.06% up from last year.
  • Per Mimedx's latest filing, its Net Income stood at $217000.0 for Q3 2024, which was up 17045.45% from $4000.0 recorded in Q2 2024.
  • In the past 5 years, Mimedx's Net Income ranged from a high of $9.8 million in Q4 2022 and a low of -$19.4 million during Q3 2020
  • In the last 5 years, Mimedx's Net Income had a median value of -$3.0 million in 2023 and averaged -$4.8 million.
  • Examining YoY changes over the last 5 years, Mimedx's Net Income showed a top increase of 483969.85% in 2022 and a maximum decrease of 51090.5% in 2022.
  • Quarter analysis of 5 years shows Mimedx's Net Income stood at -$16.6 million in 2020, then soared by 101.2% to $199000.0 in 2021, then surged by 4839.7% to $9.8 million in 2022, then crashed by 77.73% to $2.2 million in 2023, then tumbled by 90.09% to $217000.0 in 2024.
  • Its Net Income was $217000.0 in Q3 2024, compared to $4000.0 in Q2 2024 and $200000.0 in Q1 2024.